Look at Dr Lal PathLabs at lower levels: Sudip Bandopadhyay

Sudip Bandopadhyay, Market Expert told CNBC-TV18, "Dr Lal PathLabs is an excellent company. A company which gives 24-25 percent return is a great story but having said that the valuations at current level looks a bit stretched. Somewhere when the multiple gets in the range of 40-50 one becomes a little uncomfortable. So, we are not advising investors to get into Dr Lal Pathlabs at this valuation. As and when and if the valuation does correct it is definitely a story to participate in but not at this valuation."Dr Lal PathLabs ended at Rs 893.65, up Rs 69.50, or 8.43 percent on the BSE.